Finished
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).
NCT04187209 · Wandercraft · Updated 26 Sept 2024
- What is being tested
- Use of the Atalante exoskeleton
- For
- Stroke; Stroke, Acute; Stroke, Subacute; Robotics
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 14 people. The full rules are on the registry page.
- Where
- France (3 sites)
- When
- Starts or started 11 Sept 2019, ends 13 Jan 2021. Registered 5 Dec 2019.
- Results
- None posted yet.
In the researchers' words
The SPIRIT study is interventional, national, prospective, open, multicentric each patient being his/her own control. It is conducted to assess the safety and performance of the Atalante exoskeleton system in patients presenting a non-traumatic acute-subacute hemiplegia. The primary endpoint is defined by the patient's ability to perform the 10 MWT with the Atalante system. The study will include at least 12 patients and takes place in three french rehabilitation centers.
Sites
- Centre Jacques Calvé - Fondation HopaleBerck, France
- Centre de Médecine Physique et de Réadaptation de PionsatPionsat, France
- Centre mutualiste de Rééducation et de Réadaptation de KerpapePloemeur, France